The incidence and survival of acute de novo leukaemias in Estonia and in a well-defined region of western Sweden during 1982-1996: A survey of patients aged ≥65 years

Journal of Internal Medicine

Volumn 256, Issue 1, 2004, Pages 79-85

  Luik, E ^a   Palk, K ^b   Everaus, H ^a   Varik, M ^b   Aareleid, T ^c,d   Wennstrom L ^e   Juntikka, E L ^e   Safai Kutti, S ^e   Stockelberg, D ^e   Holmberg, E ^f   Kutti, J ^e,f  

^a TARTU UNIVERSITY CLINICS   (Estonia)

^b Department of Hematology ^*  (Estonia)

^c North Estonian Regional Hospital   (Estonia)

^d NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^e Department of Medicine   (Sweden)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute de novo leukaemia; Estonia; Incidence; Survival; Sweden

Indexed keywords

AGED; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ECONOMIC ASPECT; ENVIRONMENTAL FACTOR; ESTONIA; FEMALE; HEALTH CARE; HEALTH SURVEY; HUMAN; INCIDENCE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; POLITICS; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SWEDEN;

AGED; DELIVERY OF HEALTH CARE; ENVIRONMENT; ESTONIA; FEMALE; HUMANS; INCIDENCE; LEUKEMIA; MALE; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL RATE; SWEDEN;

EID: 3042691731     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2004.01335.x     Document Type: Review

References (15)

1. Wennström L, Juntikka E-L, Safai-Kutti S, et al. The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1982-1996: a survey of patients aged 16-64 years. Leuk Lymphoma 2004; 45: 915-21.
2. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-5.
3. Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813-9.
4. Öst Å, Reizenstein P. Minimal diagnostic criteria for the myelodysplastic syndrome. Leuk Res 1992; 16: 9-11.
5. Rothman KJ. Modern Epidemiology. Boston: Little, Brown and Company, 1986.
6. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed 1985; 19: 197-207.
7. Hakulinen T, Tenkanen L, Abeywickrama K, Päivärinta L. Testing equality of relative survival patterns based on aggregated data. Biometrics 1987; 43: 313-25.
8. Taylor PRA, Reid MM, Stark AN, Bown N, Hamilton PJ, Proctor SJ. De novo acute myeloid leukaemia in patients over 55-years-old: a population-based study of incidence, treatment and outcome. Leukemia 1995; 9: 231-7.
9. Taylor PRA, Reid MM, Bown N, Hamilton PJ, Proctor SJ. Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome. Blood 1992; 80: 1813-7.
10. Åström M, Bodin L, Tidefelt U. Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population. Leuk Lymphoma 2001; 41: 559-70.
11. Lang K, Mägi M, Aareleid T. Study of completeness of registration at the Estonian cancer registry. Eur J Cancer Prev 2003; 12: 153-6.
12. Nilsson B, Gustavson-Kadaka E, Hakulinen T et al. Cancer survival in Estonian migrants to Sweden. J Epidemiol Community Health 1997; 51: 418-23.
13. Hiddemann W, Kern W, Schoch C et al. Management of acute myeloid leukemia in elderly patients. J Clin Oncol 1999; 17: 3569-76.
14. Wahlin A, Markevärn B, Golovleva I, Nilsson M. Prognostic significance of risk group stratification in elderly patients with acute myeloid leukemia. Br J Haematol 2001; 115: 25-33.
15. Öberg G, Killander A, Björeman M et al. Long-term follow-up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapy. A randomized trial of aclarubicin vs. daunorubicin in combination with cytosine arabinoside and thioguanine. Eur J Haematol 2002; 68: 376-81.